Immunoprecipitation Testing Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||921901|
|出版日期||內容資訊||英文 113 Pages
|全球免疫沉澱測試市場:成長，趨勢，及預測(2020年∼2025年) Immunoprecipitation Testing Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 113 Pages||
The major factor driving the growth of the Immunoprecipitation Testing market is the rise in the prevalence of the immunology cases which requires antibody-antigen interaction testing. Furthermore, increasing funding from the government and non-government organizations to carry out researches on next-generation DNA sequencing and genomics is fuelling the market growth. Along with that, the growing applications of Immunoprecipitation Testing in central nervous disorders, cancers, and cardiovascular diseases are also boosting the growth of the Immunoprecipitation Testing market.
For instance, in 2019, Merck & Co. Inc. announced that it is going to establish a new life science hub focusing on areas such as oncology, immunology, and immuno-oncology. However, few constraints of Immunoprecipitation Testing such as limitations in sample size, variations in lipid content might hamper the usage of this test which is expected to impede the market growth.
As per the scope of this report, Immunoprecipitation (IP) is a precipitation procedure which purifies and enriches the selected protein, by allowing the identification of protein-protein interactions in proteomics workflows. IP is a vital technique used to investigate the presence, size, downregulation or up-regulation, relative abundance, post-translational modifications (PTMs), stability and interactions between proteins.
Chromatin immunoprecipitation (ChIP) segment holds significant market share
Asia is the fastest-growing region in the Global Immunoprecipitation Testing Market
Asia-Pacific is expected to be the fastest-growing region in the Global Immunoprecipitation Testing market owing to the increasing investments and funding from the governments especially in biotechnology research, and growing awareness regarding personalized medicine. Additionally, growing collaborations and partnerships between organizations and universities are emerging in this region.
The North American region holds the largest share in the market globally. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute), have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease.
The immunoprecipitation Testing market has rapidly evolved over the last few years. Industry observed significant changes in adopting market strategies such as product developments, mergers, and acquisitions in recent years. Thus, the Immunoprecipitation Testing market has become a very competitive industry. Key developments in the market are Abbkine launched Agarose/Magnetic beads Conjugated Tag Antibodies, facilitating a rapid and simple tagged protein immunoprecipitation process in 2018.